Sionna Therapeutics, Inc.
Regulated industrySells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $3.07
- 52-Week Range
- $2.89 – $54.97
- Market Cap
- $134.35M
- P/E (TTM)
- —
- EPS (TTM)
- -2.43
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.56
- PEG Ratio
- —
- Return on Equity
- -38.96%
- Return on Assets
- -23.71%
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Profit Margin
- 0.00%
- Current Ratio
- 13.92
- Debt/Equity
- 0.03
- Total Debt
- $7.75M
- Free Cash Flow
- $-40.31M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $-82.49M
Market Snapshot
About
Sionna Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for inflammatory and fibrotic diseases. The company utilizes its proprietary TRADE platform to discover and develop small molecule therapeutics targeting critical disease pathways.